According to Madrigal Pharmaceuticals
's latest financial reports the company has S$1.24 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | S$1.25 B | 50.33% |
2023-12-31 | S$0.83 B | 74.13% |
2022-12-31 | S$0.48 B | 31.6% |
2021-12-31 | S$0.36 B | -2.77% |
2020-12-31 | S$0.37 B | -36.49% |
2019-12-31 | S$0.59 B | -10.43% |
2018-12-31 | S$0.66 B | 157.97% |
2017-12-31 | S$0.25 B | 337.03% |
2016-12-31 | S$58.61 M | 13430.9% |
2015-12-31 | S$0.43 M | -99.66% |
2014-12-31 | S$0.12 B | 11.38% |
2013-12-31 | S$0.11 B | -5.79% |
2012-12-31 | S$0.12 B | 139.13% |
2011-12-31 | S$51.44 M | -21.65% |
2010-12-31 | S$65.65 M | 5.92% |
2009-12-31 | S$61.98 M | -41.08% |
2008-12-31 | S$0.10 B | -36.75% |
2007-12-31 | S$0.16 B | 131.64% |
2006-12-31 | S$71.79 M | -30.51% |
2005-12-31 | S$0.10 B | -49.32% |
2004-12-31 | S$0.20 B | 57.42% |
2003-12-31 | S$0.12 B |